Home › Focal Segmental Glomerulosclerosis › Minnesota › Minneapolis
Focal Segmental Glomerulosclerosis clinical trials in Minneapolis, MN
3 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Recruiting
- University of Minnesota, Minneapolis
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
RecruitingPhase 2
- University of Minnesota, Masonic Children's Hospital, Minneapolis
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
RecruitingPhase 3
- University of Minnesota, Minneapolis
Focal Segmental Glomerulosclerosis trials in other cities
- Philadelphia, PA9 studies
- Durham, NC8 studies
- New York City, NY7 studies
- Ann Arbor, MI6 studies
- Miami, FL6 studies
- Los Angeles, CA6 studies
- Queens, NY6 studies
- Atlanta, GA5 studies
- Houston, TX5 studies
- Cleveland, OH4 studies
- Chicago, IL4 studies
- Dallas, TX4 studies
Other studies in Minneapolis
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Ovarian Cancer24 studies
- Prostate Cancer23 studies
- Cancer (all types)22 studies
- Heart Failure21 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Colorectal Cancer19 studies
- Endometrial Cancer18 studies
- Parkinson's Disease17 studies
- Cardiovascular Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.